MedKoo Cat#: 556356 | Name: ART838

Description:

WARNING: This product is for research use only, not for human or veterinary use.

ART838 is a 2-Carbon-Linked Dimeric Artemisinin With Potent Antileukemic Activity and Favorable Pharmacology. ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs. ART-838 was 88-fold more potent that artesunate in vitro, inhibiting all leukemia cell lines at submicromolar concentrations. Both ART-838 and artesunate cooperated with several established antileukemic drugs and newer kinase inhibitors to inhibit leukemia cell growth. ART-838 had a longer plasma half-life than artesunate in immunodeficient NOD-SCID-IL2Rgnull (NSG) mice, remaining at effective antileukemic concentrations for >8h. Intermittent cycles of ART-838 inhibited growth of acute leukemia xenografts and primagrafts in NSG mice, at higher potency than artesunate .

Chemical Structure

ART838
CAS#676620-45-4

Theoretical Analysis

MedKoo Cat#: 556356

Name: ART838

CAS#: 676620-45-4

Chemical Formula: C46H63O12P

Exact Mass: 838.4057

Molecular Weight: 838.97

Elemental Analysis: C, 65.86; H, 7.57; O, 22.88; P, 3.69

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
ART838; ART-838; ART 838;
IUPAC/Chemical Name
C[C@@H]1CCC2[C@@]34C1CC[C@@](O[C@H]4O[C@H](CC(C[C@H]5O[C@@H]6O[C@]7(C)OO[C@]6(C8CC7)C([C@H]5C)CC[C@H]8C)COP(OC9=CC=CC=C9)(OC%10=CC=CC=C%10)=O)[C@@H]2C)(C)OO3
InChi Key
OOPQGVUXVFNNDO-ILVOEFJHSA-N
InChi Code
InChI=1S/C46H63O12P/c1-28-17-19-37-30(3)39(49-41-45(37)35(28)21-23-43(5,51-41)55-57-45)25-32(27-48-59(47,53-33-13-9-7-10-14-33)54-34-15-11-8-12-16-34)26-40-31(4)38-20-18-29(2)36-22-24-44(6)52-42(50-40)46(36,38)58-56-44/h7-16,28-32,35-42H,17-27H2,1-6H3/t28-,29-,30-,31-,32?,35?,36?,37?,38?,39-,40-,41-,42-,43-,44-,45-,46-/m1/s1
SMILES Code
C[C@@H]1CCC2[C@@]34C1CC[C@@](O[C@H]4O[C@H](CC(C[C@H]5O[C@@H]6O[C@]7(C)OO[C@]6(C8CC7)C([C@H]5C)CC[C@H]8C)COP(OC9=CC=CC=C9)(OC%10=CC=CC=C%10)=O)[C@@H]2C)(C)OO3
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 838.97 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Fox JM, Moynihan JR, Mott BT, Mazzone JR, Anders NM, Brown PA, Rudek MA, Liu JO, Arav-Boger R, Posner GH, Civin CI, Chen X. Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs. Oncotarget. 2016 Feb 9;7(6):7268-79. doi: 10.18632/oncotarget.6896. PMID: 26771236; PMCID: PMC4872784.